Synovo GmbH

General information
Synovo GmbH
Paul-Ehrlich Str. 15
72076 Tübingen, Baden-Württemberg
Germany

Contact person: Michael Burnet, Managing Director
Company main phone: +49 (7071) 964325
Company main fax:  +49 (7071) 964326
Website:  www.synovo.com
Year founded:2004
Source of foundation:Independent foundation
Corporate description / mission:
Synovo GmbH is a pharmaceutical research company which combines in-house research and pharmaceutical discovery services. The company's in house research mainly focus on inflammation, infection, oncology, ophthalmology, and formulation. Besides the pharmaceutical development, the company has significant expertise in synthetic chemistry and the formulation or modification of antibodies.
State of ownership: Private / independent
Headquarters: Yes
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Other
  • Analytical services
  • Cell culture
  • CRO (Contract Research Organization)
  • Drug delivery
  • Screening
  • Synthesis services
Primary therapeutic areas:
  • Digestive system / gastroenterology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the ear / otology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Respiratory / pulmonology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • In-licensing
  • Out-licensing
  • R&D
  • Research on contract basis
  • Service company
Customer segments:
  • Large biotech & big pharma
  • Large medtech
  • Small biotech
  • Small medtech
Summary Products / Services / Technologies
Number of Biotech Products
Pre-clinical:8
Phase I:1
Number of Medtech Products
In development:1
Description of products:
Services
pharmacology :

Cell culture
Microbiology
PK/PD
Analytics
Formulation

chemistry :
Synthesis of specific intermediates or screening compounds
Method optimization and scale-up
Immobilisation of ligands
ADME optimization
Preparation of fluorescent conjugates, etc.
© 2021 Biotechgate by Venture Valuation
X